|
⚲
|
| Keyboard |
| David U'Prichard | |
|---|---|
| Firm | |
| Address | 20 Berkeley Square London, X0 W1J 6EQ |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Arix Bioscience PLC | 021-309307 | Director | 21.4 M of 121.8 M |
||
| Arix Bioscience PLC | 021-282151 | Director | 17.9 M of 124.6 M |
||
| VALA Sciences Inc | 021-248424 | Director | 2.0 M of 3.0 M |
||
| ORCA Pharmaceuticals LLC | 021-202057 | Director | 2.6 M of 5.0 M |
||
| Dual Therapeutics LLC | 021-199836 | Director | 6.4 M of 15.3 M |
||
| Cyclacel Pharmaceuticals Inc | 021-177527 | Director | 3.0 M of 3.0 M |
||
| Naurex Inc | 021-160088 | Director | 11.0 M | ||
| Cyclacel Pharmaceuticals Inc | 021-149447 | Director | 15.2 M of 22.2 M |
||
| Silence Therapeutics PLC | 021-137425 | Director | of 8.5 M |
||
| Life Technologies Corp | 021-137196 | Director | |||
| Naurex Inc | 021-132513 | Director | 1.1 M | ||